Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

Bengaluru: The Karnataka government has initiated prosecution against Paschim Banga Pharmaceuticals after five women died following C-section deliveries in Ballari district, where they were administered the company’s IV fluid.

Health Minister Dinesh Gundu Rao told the Assembly on Thursday that the government is seeking compensation for the bereaved families. “A child has lost its mother. We can’t let this go. Though compensation cannot bring back lives, the company must be held liable,” Rao said.

The deaths occurred at Ballari District Hospital in November. A medical panel from Rajiv Gandhi University of Health Sciences has ruled out medical negligence, pointing to the Ringer’s Lactate solution manufactured by Paschim Banga as the suspected cause.

Multiple batches of the IV fluid failed quality tests in Karnataka laboratories. Drug Controllers in five districts – Shivamogga, Chikkamagaluru, Haveri, Bengaluru, and Gadag – have filed complaints in jurisdictional courts between December 7-9.

In Shivamogga, charges have been filed under Sections 18(a)(i) and 27(d) of the Drugs and Cosmetics Act. The offences carry imprisonment between one to two years and a minimum fine of Rs 20,000 for manufacturing and selling substandard or spurious drugs.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit